AtriCure Pays $3.8M to Settle With U.S.

November 20th, 2009 by Qui Tam

The manufacturer of devices for treatment of atrial fibrillation (irregular heartbeats) tentatively settled with the US Department of Justice allegations of false claims for $3.8 million.  The DOJ claimed that the manufacturer, AtriCure, marketed its devices beyond the scope of its FDA clearance and by instructing hospitals to use incorrect Medicare billing codes. 

More information about the lawsuit can be found at the following link:

Leave a Reply